Journal of Nobel Medical College Teaching Hospital

Vol. 10 No. 2

Home Issue Vol. 10 No. 2 2021 Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report

Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report

Sushmita Khanal Department of Intensive Care Unit, Department of Cardiology,
Nobel Medical College Teaching Hospital, Biratnagar, Nepal
Sunil Babu Khanal Department of Intensive Care Unit, Department of Cardiology,
Nobel Medical College Teaching Hospital, Biratnagar, Nepal
DOI: https://doi.org/10.3126/jonmc.v10i2.41790
Tags : COVID-19 Vaccines, Guillain-Barre Syndrome

Abstract

Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the aforementioned vaccine.
PDF
Published
2021-01-02
Issue
2021-01-02
Section
Case Reports

JONMC is indexed in and associated with